Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Modular’s Pivot Tubeless Insulin Patch Pump to Pump up the Insulin Market
09 February 2026

Modular’s Pivot Tubeless Insulin Patch Pump to Pump up the Insulin Market

Introduction Modular Medical, Inc. is a development enthusiast medical device company who marketise/sell simple and sober patch pump for diabetes (Type1 and 2). The company’s crown is its 3-day patch pump, which highlights the reusable, convenient, simple 2-part design. Commercialising afford...

BMS's new perspective is an eye-opener for many healthcare giants
06 February 2026

BMS's new perspective is an eye-opener for many healthcare giants

Introduction Bristol Myers Squibb (BMS), a biopharmaceutical company, consistently aims on providing innovative drugs with the apt development and discovery strategies. The company’s ruling areas are hematology, cardiovascular, immunology and oncology disease, keeping R&D close to the hea...

Will OncoMate® MSI Detection Kit ease China’s cancer burden?
06 February 2026

Will OncoMate® MSI Detection Kit ease China’s cancer burden?

Introduction The National Medical Products Administration (NMPA) is the main regulatory body of China. This regulatory body assesses the safety measures and represents medical devices, cosmetics and drugs. Further, those products continue to be commercialised in their respective vast markets legall...

Will the Pharma Industry reveal its pricing strategy?
04 February 2026

Will the Pharma Industry reveal its pricing strategy?

What matters after medicine accessibility? For drug availability and adopting precision medicine trends, the healthcare giants moved mountains through their clinical trials, investment and kind partnership act. The roles and responsibilities have commendably crossed the bridge, but now, price trans...

U.S. Company Healthcare Workshop Highlights
04 February 2026

U.S. Company Healthcare Workshop Highlights

Workshop digs into all fundamental points This workshop encompassed major topics that bothered the U.S.-based healthcare companies, involving oath, challenges, discussion and more in the limelight. Libya Herald got a confirmation from AmCham Libya regarding this first-ever and much required U.S Com...

Lilly pinned Pennsylvania to feature its new endeavours
04 February 2026

Lilly pinned Pennsylvania to feature its new endeavours

Introduction Eli Lilly and Company is a reputable name and a force in the healthcare sector, serving largely directly from its mainland Indiana. It's smart brains in drugs, especially for obesity, immunology, oncology and diabetes. It makes billions in profit and has one of the highest revenues in ...

Signios’s new program, along with 10x Genomics, eases researchers' operations
30 January 2026

Signios’s new program, along with 10x Genomics, eases researchers' operations

Introduction Signios Bio is a part of MedGenome and provides expertise in bioinformatics and multiomics. The company is sincerely focused on leveraging medicine discovery and precision medicine. Signios delivers a package of services covering NGS, long-read sequencing and AI-inspired bioinformatics...

Lexicon’s ‘Get set go’ attitude after entering Phase 3
28 January 2026

Lexicon’s ‘Get set go’ attitude after entering Phase 3

Introduction Lexicon Pharmaceuticals entered the competition in 1995 with its excellent small molecule drugs harnessed with gene knockout technology. The main target of the company is chronic issues in oncology, neurology and cardiometabolism. Its popular products like LX9211 and INPEFA are a boon ...

J&J’s eyes are on $100 billion
27 January 2026

J&J’s eyes are on $100 billion

Introduction Johnson & Johnson is a well-known company, recognised for its MedTech innovations and effective, innovative pharmaceuticals. Since 1886, the company has contributed to and advanced the journey in the vast healthcare sector with greater confidence and dedication, poised to thrive in...

Biohaven into the battlefield with Lilly
23 January 2026

Biohaven into the battlefield with Lilly

Introduction Biohaven Biopharmaceutical Company is recognised for its expertise in developing, marketing, and exploring innovative treatments for conditions such as immunology, oncology, and neuropsychiatric disorders. The company aims to expand and accelerate its exclusive platforms for protein de...